Uncover the critical elements of a robust due diligence process that enables pharma, biotech, and VC leaders to identify opportunities, mitigate risks, and lay the groundwork for successful collaborations and investments.
- Examine innovative approaches to scientific, financial, and operational assessments during due diligence.
- Understand how cross-functional collaboration enhances efficiency and reduces blind spots in deal evaluation.
- Explore lessons from real-world deals where due diligence transformed outcomes and maximized value.